Touyun Biotech Releases 2026 Interim Report and Details Shareholder Communication Arrangements

Bulletin Express09-16

Touyun Biotech Group Limited announced that its 2026 Interim Report, dated 16 September 2026, is now available in both English and Chinese on the company’s website (www.touyunbiotech.com.hk) and on HKEXnews (www.hkexnews.hk).

Registered shareholders are encouraged to access the digital version. Those preferring hard copies may request them free of charge by completing and returning the reply form to the Hong Kong branch share registrar, Tricor Investor Services Limited, located at 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong, or by emailing 1332-ecom@vistra.com.

Touyun Biotech emphasised that shareholders must provide a valid email address to receive electronic notices of future corporate communications and actionable documents. Until a functional email address is supplied, related notices will be sent in printed form.

Shareholder enquiries can be directed to the registrar’s hotline at +852 2980 1333 (09:00–18:00, Monday to Friday, excluding public holidays).

The statement was issued under the authority of Chairman Wang Liang.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1155928859?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-16 17:05","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1155928859","market":"us","top_or_hot":-1,"title":"Touyun Biotech Releases 2026 Interim Report and Details Shareholder Communication Arrangements","media":"Bulletin Express","content":"<p>Touyun Biotech Group Limited announced that its 2026 Interim Report, dated 16 September 2026, is now available in both English and Chinese on the company’s website (www.touyunbiotech.com.hk) and on HKEXnews (www.hkexnews.hk).</p>\n<p>Registered shareholders are encouraged to access the digital version. Those preferring hard copies may request them free of charge by completing and returning the reply form to the Hong Kong branch share registrar, Tricor Investor Services Limited, located at 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong, or by emailing 1332-ecom@vistra.com.</p>\n<p>Touyun Biotech emphasised that shareholders must provide a valid email address to receive electronic notices of future corporate communications and actionable documents. Until a functional email address is supplied, related notices will be sent in printed form.</p>\n<p>Shareholder enquiries can be directed to the registrar’s hotline at +852 2980 1333 (09:00–18:00, Monday to Friday, excluding public holidays).</p>\n<p>The statement was issued under the authority of Chairman Wang Liang.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Touyun Biotech Releases 2026 Interim Report and Details Shareholder Communication Arrangements</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTouyun Biotech Releases 2026 Interim Report and Details Shareholder Communication Arrangements\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-09-16 17:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Touyun Biotech Group Limited announced that its 2026 Interim Report, dated 16 September 2026, is now available in both English and Chinese on the company’s website (www.touyunbiotech.com.hk) and on HKEXnews (www.hkexnews.hk).</p>\n<p>Registered shareholders are encouraged to access the digital version. Those preferring hard copies may request them free of charge by completing and returning the reply form to the Hong Kong branch share registrar, Tricor Investor Services Limited, located at 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong, or by emailing 1332-ecom@vistra.com.</p>\n<p>Touyun Biotech emphasised that shareholders must provide a valid email address to receive electronic notices of future corporate communications and actionable documents. Until a functional email address is supplied, related notices will be sent in printed form.</p>\n<p>Shareholder enquiries can be directed to the registrar’s hotline at +852 2980 1333 (09:00–18:00, Monday to Friday, excluding public holidays).</p>\n<p>The statement was issued under the authority of Chairman Wang Liang.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01332","symbol_name":"透云生物","start_time":0,"source_url":"","article_id":"1155928859","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1155928859","pubTimestamp":1789549517,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Touyun Biotech Group Limited announced that its 2026 Interim Report, dated 16 September 2026, is now available in both English and Chinese on the company’s website (www.touyunbiotech.com.hk) and on...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01332":"透云生物"},"translate_title":"透云生物发布2026年中期报告及股东沟通安排详情","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01332":1},"content_text":"Touyun Biotech Group Limited announced that its 2026 Interim Report, dated 16 September 2026, is now available in both English and Chinese on the company’s website (www.touyunbiotech.com.hk) and on HKEXnews (www.hkexnews.hk).\nRegistered shareholders are encouraged to access the digital version. Those preferring hard copies may request them free of charge by completing and returning the reply form to the Hong Kong branch share registrar, Tricor Investor Services Limited, located at 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong, or by emailing 1332-ecom@vistra.com.\nTouyun Biotech emphasised that shareholders must provide a valid email address to receive electronic notices of future corporate communications and actionable documents. Until a functional email address is supplied, related notices will be sent in printed form.\nShareholder enquiries can be directed to the registrar’s hotline at +852 2980 1333 (09:00–18:00, Monday to Friday, excluding public holidays).\nThe statement was issued under the authority of Chairman Wang Liang.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1155928859","isCrawlerRequest":true}